Zosano Pharma

Fremont, United States Founded: 2006 • Age: 20 yrs Listed
Develops innovative transdermal drug delivery technologies for various therapeutic applications.

About Zosano Pharma

Zosano Pharma was a Healthcare company based in Fremont (United States) founded in 2006. It develops innovative transdermal drug delivery technologies for various therapeutic applications. It operates on a B2B model. Zosano Pharma has raised $147.16 million across 13 funding rounds from investors including Nomura, Trinity Cap and HBM Healthcare Investments. The company has 40 employees. The company is recorded as dissolved. Its focus areas include Pharmaceuticals, Drug Delivery and Transdermal Systems. Its legal entity is ZOSANO PHARMA CORPORATION. Its competitors include Kriya Therapeutics, Sana Biotechnology and Semma Therapeutics; 3 of its 3 listed competitors have raised funding.

Company details

Zosano Pharma develops innovative transdermal drug delivery technologies for various therapeutic applications through providing healthcare solutions, producing pharmaceutical products, drug delivery, and transdermal systems. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

  • Headquarters Fremont, United States
  • Employees 40
  • Stage Public
  • Sectors
    Healthcare
  • Website zosanopharma.com
  • Legal Name Zosano Pharma Corporation
Key Metrics
  • Total Equity Funding
    $147.16M (USD)

    in 13 rounds

  • Latest Funding Round
    $14M (USD), Debt – Venture

    Sep 2018

  • Investors
    Nomura

    & 5 more

  • Employee Count
    40

Funding Insights of Zosano Pharma

Zosano Pharma has successfully raised a total of $147.16M across 13 strategic funding rounds. The most recent funding activity was a Debt – Venture round of $14 million completed in September 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $147.16M
  • Total Rounds 13
  • Last Round Debt – Venture β€” $14M
  • First Round $90M

    (Nov 2007)

  • Investors Count 6

Latest 10 of 13 funding rounds of Zosano Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2018$14MDebt – Venture––
Jun 2018Post-IPO––
Aug 2016$7.54MPost-IPO––
–
Jan 2015$15MPost-IPO––
–
Dec 2014$1.33MSeries B––
–
Feb 2014$3.1MSeries B––
–
Nov 2013$365,000Series B––
–
Sep 2013$3.03MSeries B––
–
Sep 2011$4.71MSeries B––
–
Aug 2010$3.11MSeries B––
–
Valuation history

6 investors in total: 6 institutional.

Investors in Zosano Pharma

Zosano Pharma has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Nomura, Trinity Cap and HBM Healthcare Investments.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Venture debt and equipment financing are provided to growth-stage companies.
2008trinitycap.comPhoenix, United States
PE firm investing in the US
aislingcapital.comNew York, United States
Venture capital investments are offered to startups by NEA.
nea.comMenlo Park, United States
proquestvc.com
Life sciences focused VC firm funding companies in the US and Europe
2001hbmhealthcare.comZug, Switzerland
Diversified asset management services are offered globally by the firm.
1925nomura.comChuo City, Japan
Premium access

Investor details for Zosano Pharma

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Zosano Pharma

14 people are tracked at Zosano Pharma (7 in leadership, 7 in team); the tracked headcount is 40.

NameRoleGroup
Kristina Warga
VP, Corporate ControllerLeadership
Mahmoud Ameri
VP, Research & DevelopmentLeadership
Christine Matthews
CFOLeadership
Donald Kellerman
VP, Clinical Development & Medical AffairsLeadership
Brian Minh Nguyen
Director, Financial Planning & AnalysisLeadership
Lu Liu
VP, Technical OperationsLeadership
Jim Mellers
Associate Director Equipment Engineering MaintenanceLeadership
Michael Magnano
Senior Project ManagerTeam
Jessica Heasley
System Design EngineerTeam
Michael Abriam
ManufacturingTeam
Julie Davilla
Manager, Process DevelopmentTeam
Amy Khuu
Senior QA SpecialistTeam
Trong Nguyen
ManagerTeam
Phuong Nguyen
Materials Handler . 3rdTeam
Premium access

Complete people profiles for Zosano Pharma

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Zosano Pharma

4 dated milestones of Zosano Pharma across 12 years, from founding to its latest funding, stage changes and deals.

  1. Founded Zosano Pharma is founded.
  2. Funding First funding round of $90.0M.
  3. IPO Lists on the stock exchange (IPO).
  4. Funding Latest funding round, Debt – Venture, of $14.0M.

Competitors of Zosano Pharma

Zosano Pharma has 3 listed competitors in our database, 3 of them funded. They include Kriya Therapeutics, Sana Biotechnology and Semma Therapeutics.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
kriyatherapeutics.com2012Redwood, United States$930.93M159
Developer of therapeutic solutions for the treatment of diabetes
sana.com2018Seattle, United States$821M328
Genetically engineered cell therapies are developed for multiple disorders.
semma-tx.com2015Cambridge, United States$158M58
Provider of bio-artificial pancreas for Type 1 Diabetes treatment
Premium access

Detailed competitors of Zosano Pharma

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Pharmacy & Healthcare Retail Systems

3 companies that operate in the same segment as Zosano Pharma (Pharmacy & Healthcare Retail Systems) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Alto Pharmacy is focused on providing convenient prescription delivery services.
2015San Francisco, California, United StatesUSD 591.64 M802
Optum is recognized as a leading health solution and care delivery organization.
2011Eden Prairie, Minnesota, United StatesUSD 250 KUSD 383.36 M140
Materials management and business analytics solutions for healthcare are provided.
1992Mountain View, California, United StatesUSD 20 MUSD 1.18 B3,670
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Zosano Pharma

Premium access

Complete news archive for Zosano Pharma

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Zosano Pharma

Zosano Pharma was founded in 2006 and raised its 1st funding round 1 year after it was founded.

Zosano Pharma is headquartered in Fremont, United States. It is registered at Fremont, California, United States.

Zosano Pharma is a funded company, having raised a total of $147.16M across 13 funding rounds to date. The company's 1st funding round was a Series B of $3.11M, raised on Nov 2007.

Zosano Pharma has 40 employees.

Zosano Pharma develops innovative transdermal drug delivery technologies for various therapeutic applications through providing healthcare solutions, producing pharmaceutical products, drug delivery, and transdermal systems. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

Zosano Pharma's top competitors include Sana Biotechnology, Semma Therapeutics and Kriya Therapeutics.

Zosano Pharma has 6 investors. Key investors include Nomura, Trinity Cap, HBM Healthcare Investments, Aisling Capital, and NEA.

Zosano Pharma operates through Zosano Pharma Corporation.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available